Using a method of contraception must be made sure to prevent pregnancy during treatment with Hemator and for 15 days after ending treatment. Patients must be advised to inform the doctor immediately if she become pregnant while taking this medicine.
Patients must be advised to inform the doctor if she is pregnant or planning to become pregnant.
This medicine may be harmful to the unborn baby. If it is necessary to take it during pregnancy, the doctor will discuss the risks and benefits involved.
Patients must be advised to inform the doctor if she is breast-feeding.
It is not known if the active ingredient, imatinib, passes into the breast milk. Because this medicine could affect the baby, breast-feeding is not recommended.